Amoxicillin As Amoxicillin Trihydrate; Clavulanate Potassium ( K-Clavulanate)

Verify with FDA CVM →

255 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
255
Total Reports
10
Deaths Reported
390.0%
Death Rate

Active Ingredients

Amoxicillin As Amoxicillin Trihydrate; Clavulanate Potassium ( K-Clavulanate)

Administration Routes

UnknownOralOphthalmic

Species Affected

Unknown 168
Dog 58
Cat 27
Rabbit 1
Human 1

Most Affected Breeds

Unknown 169
Domestic Shorthair 19
Retriever - Labrador 7
Retriever - Golden 5
Dachshund (unspecified) 3
Spitz - German Pomeranian 2
Shepherd Dog - Australian 2
Pug 2
Beagle 2
Chihuahua 2

Most Reported Reactions

Color, Abnormal 158
Suspension, Abnormal 120
Uncoded sign 43
Lack of efficacy (bacteria) - NOS 21
Lethargy (see also Central nervous system depression in 'Neurological') 19
Vomiting 18
Other abnormal test result NOS 13
Anorexia 12
Leucocytosis NOS 11
Ataxia 10
Lack of efficacy - NOS 10
Seal, Abnormal 10

Outcome Breakdown

Ongoing
53 (60.9%)
Recovered/Normal
14 (16.1%)
Outcome Unknown
9 (10.3%)
Euthanized
6 (6.9%)
Died
4 (4.6%)
Recovered with Sequela
1 (1.1%)

Data Summary

Metric Value
Total adverse event reports 255
Reports involving death 10
Case-fatality rate (reported events) 390.0%
Distinct species in reports 5
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Amoxicillin As Amoxicillin Trihydrate; Clavulanate Potassium ( K-Clavulanate) Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 255 adverse event reports referencing Amoxicillin As Amoxicillin Trihydrate; Clavulanate Potassium ( K-Clavulanate), including 10 reports in which the animal died — a 390.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Amoxicillin As Amoxicillin Trihydrate; Clavulanate Potassium ( K-Clavulanate). Reported administration routes include Unknown, Oral, Ophthalmic. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Amoxicillin As Amoxicillin Trihydrate; Clavulanate Potassium ( K-Clavulanate) reports are Unknown (168 reports), Dog (58 reports), Cat (27 reports), with Unknown accounting for the largest share. Within those species, Unknown (169), Domestic Shorthair (19), Retriever - Labrador (7) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Amoxicillin As Amoxicillin Trihydrate; Clavulanate Potassium ( K-Clavulanate) are Color, Abnormal (158), Suspension, Abnormal (120), Uncoded sign (43), Lack of efficacy (bacteria) - NOS (21). Of the 87 reports with a coded outcome, Ongoing is the leading category at 60.9%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Amoxicillin As Amoxicillin Trihydrate; Clavulanate Potassium ( K-Clavulanate).

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial